Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:01 pm Sale | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Cormorant Asset Management LP | 0 0.000% | -1,971,739 (Position Closed) | Filing History |
| 2024-02-14 09:20 am Sale | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Lynx1 Capital Management LP | 2,139,644 4.990% | -686,332 (-24.29%) | Filing History |
| 2024-02-13 6:47 pm Unchanged | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Bain Capital Life Sciences Opportunities III LP | 2,000,000 4.700% | 0 (Unchanged) | Filing History |
| 2024-02-13 4:31 pm Purchase | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Nichtberger Steven | 2,668,756 5.400% | 335,377 (+14.37%) | Filing History |
| 2024-02-12 5:25 pm Sale | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | Flynn James E | 2,007,729 4.690% | -332,389 (-14.20%) | Filing History |
| 2024-02-07 07:04 am Purchase | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,864,475 9.470% | 1,305,117 (+50.99%) | Filing History |
| 2024-01-24 10:07 am Purchase | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | STATE STREET CORP STT | 2,594,470 6.050% | 2,594,470 (New Position) | Filing History |
| 2024-01-08 4:35 pm Purchase | 2023-12-31 | 13G | Cabaletta Bio, Inc. CABA | BlackRock Inc. BLK | 4,409,005 10.300% | 4,409,005 (New Position) | Filing History |
| 2023-06-01 4:45 pm Purchase | 2023-05-22 | 13G | Cabaletta Bio, Inc. CABA | Bain Capital Life Sciences Opportunities III LP | 2,000,000 5.000% | 2,000,000 (New Position) | Filing History |
| 2023-05-26 3:09 pm Purchase | 2023-05-22 | 13G | Cabaletta Bio, Inc. CABA | Flynn James E | 2,340,118 5.900% | 1,875,866 (+404.06%) | Filing History |
| 2023-02-14 4:07 pm Purchase | 2022-12-31 | 13G | Cabaletta Bio, Inc. CABA | Lynx1 Capital Management LP | 2,825,976 9.700% | 465,664 (+19.73%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Cabaletta Bio, Inc. CABA | Baker Bros. Advisors LP | 1,344,000 5.200% | 1,344,000 (New Position) | Filing History |
| 2023-02-14 3:09 pm Sale | 2022-12-31 | 13G | Cabaletta Bio, Inc. CABA | Cormorant Asset Management LP | 1,971,739 6.770% | -28,261 (-1.41%) | Filing History |
| 2023-02-14 08:14 am Sale | 2022-12-31 | 13G | Cabaletta Bio, Inc. CABA | CITADEL ADVISORS LLC | 97,402 0.300% | -1,422,021 (-93.59%) | Filing History |
| 2023-02-14 07:21 am Sale | 2022-12-31 | 13G | Cabaletta Bio, Inc. CABA | Eversept Partners, L.P. | 282,874 1.000% | -1,826,218 (-86.59%) | Filing History |
| 2023-02-14 06:07 am Purchase | 2022-12-31 | 13G | Cabaletta Bio, Inc. CABA | Nichtberger Steven | 2,333,379 7.700% | 474,917 (+25.55%) | Filing History |
| 2023-02-10 4:04 pm Purchase | 2023-01-31 | 13G | Cabaletta Bio, Inc. CABA | ALGER ASSOCIATES INC | 3,478,427 11.900% | 3,478,427 (New Position) | Filing History |
| 2023-02-09 12:39 pm Purchase | 2022-12-31 | 13G | Cabaletta Bio, Inc. CABA | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,559,358 9.990% | 17,713 (+0.70%) | Filing History |
| 2023-01-13 4:05 pm Purchase | 2023-01-03 | 13G | Cabaletta Bio, Inc. CABA | Commodore Capital LP | 1,458,367 5.000% | 1,458,367 (New Position) | Filing History |
| 2022-12-23 4:15 pm Purchase | 2022-12-13 | 13G | Cabaletta Bio, Inc. CABA | Venrock Healthcare Capital Partners III L.P. | 1,895,285 6.500% | 1,895,285 (New Position) | Filing History |